FDA Clears Second Carcass-Eating Fly Species for Wound Therapy

The FDA has cleared a second species of carcass-eating fly for use in maggot wound therapy, expanding options for treating difficult infections. While robust clinical data remains limited, this approval reflects a growing acceptance of biological solutions for stubborn wounds where traditional antibiotics fail. The move represents a significant step in medical innovation, offering a fail-safe alternative to conventional treatments.